×

FDA targets 'bad' cholesterol drug

6:31 AM ET Tue, 9 June 2015

CNBC's Meg Tirrell reports the FDA meets today and tomorrow to discuss and vote on recommendation for approval of new cholesterol drugs, Praluent and Repatha.